Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Apr 9, 2020

Total Value: $276M (100.0% shares, 0.0% debt)

Holdings (40)

XBI SPDR SERIES TRUST 19.5%
Value $53.81M Shares 750,000 Est. Cost Unrealized
MIRATI THERAPEUTICS INC 6.2%
Value $16.97M Shares 400,000 Est. Cost $33.00 Unrealized
DICERNA PHARMACEUTICALS INC 4.8%
Value $13.36M Shares 1,250,000 Est. Cost $11.55 Unrealized
VRTX VERTEX PHARMACEUTICALS INC 4.8%
Value $13.26M Shares 80,000 Est. Cost $173.27 Unrealized 0.0%
IMMUNOMEDICS INC 4.1%
Value $11.42M Shares 800,000 Est. Cost $8.35 Unrealized
IMMUNOMEDICS INC 4.1%
Value $11.42M Shares 800,000 Est. Cost $8.35 Unrealized
RETROPHIN INC 4.1%
Value $11.31M Shares 500,000 Est. Cost $26.90 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 3.7%
Value $10.17M Shares 275,000 Est. Cost $37.40 Unrealized
ANAB ANAPTYSBIO INC 3.2%
Value $8.931M Shares 140,000 Est. Cost $80.01 Unrealized -7.1%
RCKT ROCKET PHARMACEUTICALS INC 3.2%
Value $8.892M Shares 600,000 Est. Cost $16.85 Unrealized -1.5%
IOVA IOVANCE BIOTHERAPEUTICS INC 3.2%
Value $8.85M Shares 1,000,000 Est. Cost $9.64 Unrealized 0.0%
KALV KALVISTA PHARMACEUTICALS INC 3.0%
Value $8.394M Shares 425,000 Est. Cost $16.62 Unrealized +21.0%
ASND ASCENDIS PHARMA A S 2.8%
Value $7.831M Shares 125,000 Est. Cost $49.12 Unrealized
SRPT SAREPTA THERAPEUTICS INC 2.8%
Value $7.639M Shares 70,000 Est. Cost $78.35 Unrealized +59.6%
OBSEVA SA 2.5%
Value $6.963M Shares 550,000 Est. Cost $11.87 Unrealized
AUDENTES THERAPEUTICS INC 2.3%
Value $6.396M Shares 300,000 Est. Cost $21.32 Unrealized
FOLD AMICUS THERAPEUTICS INC 2.3%
Value $6.227M Shares 650,000 Est. Cost $10.99 Unrealized 0.0%
TRICIDA INC 2.1%
Value $5.895M Shares 250,000 Est. Cost $30.07 Unrealized
FXF INVESCO CURNCYSHS SWISS FRAN 1.9%
Value $5.237M Shares 55,200 Est. Cost $95.31 Unrealized
ORCHARD THERAPEUTICS PLC 1.7%
Value $4.719M Shares 300,000 Est. Cost $15.73 Unrealized
VRAYQ VIEWRAY INC 1.7%
Value $4.553M Shares 750,000 Est. Cost $6.99 Unrealized +7.3%
KADMON HLDGS INC 1.5%
Value $4.16M Shares 2,000,000 Est. Cost $3.85 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.5%
Value $4.105M Shares 100,000 Est. Cost $41.55 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 1.5%
Value $4.035M Shares 500,000 Est. Cost $6.72 Unrealized +15.8%
ZAFGEN INC 1.3%
Value $3.713M Shares 750,000 Est. Cost $11.49 Unrealized
BIODELIVERY SCIENCES INTL IN 1.3%
Value $3.7M Shares 1,000,000 Est. Cost $2.94 Unrealized
MOMENTA PHARMACEUTICALS INC 1.3%
Value $3.588M Shares 325,000 Est. Cost $11.04 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.3%
Value $3.489M Shares 85,000 Est. Cost $41.55 Unrealized
SAGE THERAPEUTICS INC 1.0%
Value $2.874M Shares 30,000 Est. Cost $141.26 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.9%
Value $2.552M Shares 35,000 Est. Cost $99.19 Unrealized -22.5%
ARVN ARVINAS INC 0.8%
Value $2.249M Shares 175,000 Est. Cost $16.46 Unrealized -3.6%
ACAD ACADIA PHARMACEUTICALS INC 0.7%
Value $2.021M Shares 125,000 Est. Cost $25.20 Unrealized -22.9%
UROV UROVANT SCIENCES LTD 0.7%
Value $1.977M Shares 300,000 Est. Cost $12.00 Unrealized
CATALYST BIOSCIENCES INC 0.6%
Value $1.578M Shares 200,000 Est. Cost $25.80 Unrealized
GENOCEA BIOSCIENCES INC 0.4%
Value $1.011M Shares 3,525,000 Est. Cost $0.86 Unrealized
INTRA CELLULAR THERAPIES INC 0.3%
Value $904K Shares 79,400 Est. Cost Unrealized
PROTEOSTASIS THERAPEUTICS IN 0.2%
Value $616K Shares 190,000 Est. Cost $3.24 Unrealized
SAGE THERAPEUTICS INC 0.1%
Value $316K Shares 3,300 Est. Cost $141.26 Unrealized
MOTUS GI HLDGS INC 0.1%
Value $311K Shares 100,000 Est. Cost $4.48 Unrealized
MDGL MADRIGAL PHARMACEUTICALS INC 0.0%
Value $101K Shares 900 Est. Cost $175.60 Unrealized -11.9%